BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Nosology
,
Fluoxetine
,
rs3825942
,
DRD2
,
T cell receptor signaling pathway
,
Arthritis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
ligand
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
B-lymphocytes from PBMCs of healthy donors treated with APRIL, IFNalpha, sCD40L and SDF1
Explore Curated Studies Results
Literature
Most Relevant Literature
Investigating Protein Binding with the Isothermal Ligand-induced Resolubilization Assay.
Systematic Investigation of Dual-Target-Directed Ligands.
Utility of the Morgan Fingerprint in Structure-Based Virtual Ligand Screening.
On the relevance of query definition in the performance of 3D ligand-based virtual screening.
AutoDock-SS: AutoDock for Multiconformational Ligand-Based Virtual Screening.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Ga-68 PSMA Ligand: A Radiopharmaceutical for Localization of Prostate Cancer
FLT3 Ligand, CD40 Agonist Antibody, and Stereotactic Radiotherapy
Evaluation of the Effect of Hypoglycemia With PET and a Norepinephrine Transporter Ligand
A Study of Flt3-Ligand Levels in Sjögrens Syndrome
CD40 Ligand Expressing MSLN-CAR T Cell Therapy in MSLN Positive Advanced/Metastatic Solid Tumors
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ